Lars van der Veen

Employment

• iOnctura BV CTO
  2017 - Present

Education

• University of Amsterdam Dr
  1995 - 1999

Projects & Funding

Projects & funding information is unavailable.

Publications (2)

• The highly selective and oral phosphoinositide 3-kinase delta (PI3K-δ) inhibitor roginolisib induces apoptosis in mesothelioma cells and increases immune effector cell composition
  Translational Oncology 2024 DOI: 10.1016/j.tranon.2023.101857
  +Save
• Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib
  International Journal of Toxicology 2023 DOI: 10.1177/10915818231200419
  +Save